Natasha J. Caplen

Natasha J. Caplen is a renowned biologist and geneticist specializing in the field of RNA interference. She is currently a Senior Investigator at the National Cancer Institute (NCI), where she leads a team of researchers in the Genetics Branch.

Early Life and Education[edit | edit source]

Caplen was born and raised in the United Kingdom. She completed her undergraduate studies in Biochemistry at the University of Bath, where she developed a keen interest in the complexities of genetic structures and functions. She then pursued her Ph.D. in Molecular Biology at the University of London, focusing her research on the mechanisms of gene expression.

Career and Research[edit | edit source]

After completing her Ph.D., Caplen moved to the United States to further her research. She joined the NCI as a Postdoctoral Fellow, where she began her work on RNA interference. Her research primarily focuses on the role of microRNA and small interfering RNA in gene regulation, particularly in relation to cancer development and progression.

Caplen's work has significantly contributed to the understanding of RNA interference and its potential applications in cancer treatment. Her research has led to the development of innovative therapeutic strategies, including the use of RNAi for targeted gene silencing in cancer cells.

Recognition[edit | edit source]

Caplen's contributions to the field of RNA interference have been widely recognized. She has received numerous awards and honors for her work, including the NCI Director's Intramural Innovation Award.

Publications[edit | edit source]

Caplen has authored and co-authored numerous scientific publications in prestigious journals. Her work is frequently cited, reflecting the impact of her research in the field of RNA interference and cancer genetics.